Relay Therapeutics Inc (RLAY) — Financial Flexibility Index
Relay Therapeutics Inc (RLAY) has a Financial Flexibility Index of -0.89x as of March 2026. Free cash flow of $-51.11 Million (operating CF $-51.11 Million minus capex $0.00) represents -1% of total liabilities ($57.43 Million). Check RLAY cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Relay Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Relay Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Relay Therapeutics Inc generate cash.
Annual Financial Flexibility Index for Relay Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Relay Therapeutics Inc. Explore RLAY debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.33x | $-235.04 Million | $-235.46 Million | $54.27 Million | ▼ -63.9% |
| 2024 | -2.64x | $-247.09 Million | $-249.11 Million | $93.50 Million | ▲ +17.9% |
| 2023 | -3.22x | $-296.19 Million | $-300.32 Million | $91.98 Million | ▼ -118.5% |
| 2022 | -1.47x | $-220.43 Million | $-229.49 Million | $149.55 Million | ▼ -129.9% |
| 2021 | -0.64x | $-70.94 Million | $-74.41 Million | $110.64 Million | ▲ +76.7% |
| 2020 | -2.75x | $-100.56 Million | $-102.49 Million | $36.54 Million | ▼ -2615.3% |
| 2019 | -0.10x | $-58.13 Million | $-66.13 Million | $573.51 Million | ▼ -28.8% |
| 2018 | -0.08x | $-42.45 Million | $-44.13 Million | $539.54 Million | — |